Announcements Trials
Browse Landscape

Phase

Phase 2 166Phase 3 89Phase 1/2 35Phase 1 24Phase NA 22Phase 2/3 6Phase 4 4Phase EARLY_PHASE1 1

Status

Completed 3Active not recruiting 1

Sponsor Class

INDUSTRY 3OTHER 1

Study Type

Interventional 4

Sponsor

Cancer Type

Genitourinary 2Plasma cell 1Breast 1

Conditions

Prostatic Neoplasms 2Multiple Myeloma 1Breast Neoplasms 1

Interventions

carfilzomib 1apalutamide 1Lenalidomide 1Dexamethasone 1Androgen Antagonists 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Phase 4 × Has results × 30 days × Clear all
NCT04764292 2026-05-22

SCEMAM

University of Pittsburgh

Phase 4 Completed
615 enrolled 11 charts
Breast

Breast Neoplasms

NCT06604442 2026-05-12

Intrapatient Comparison of Urinary Radioactivity Following Piflufolastat (18F) and Flotufolastat (18F) PET in Men With Low PSA Biochemical Recurrence of Prostate Cancer Following Radical Prostatectomy

Blue Earth Diagnostics

Phase 4 Completed
62 enrolled 15 charts
Genitourinary

Prostatic Neoplasms

NCT03934684 2026-05-11

Study to Evaluate Safety Tolerability & Efficacy of Kyprolis (Carfilzomib) in Relapsed or Refractory Multiple Myeloma

Amgen

Phase 4 Completed
101 enrolled 14 charts
Plasma cell

Multiple Myeloma

NCT04108208 2026-05-11

A Study of Apalutamide in Chinese Participants With Non Metastatic Castration Resistant Prostate Cancer (NM-CRPC)

Janssen Research & Development, LLC

Phase 4 Active not recruiting
75 enrolled 9 charts
Genitourinary

Prostatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡